Frank Scholz - Mallinckrodt Public Insider

MNK -- USA Stock  

USD 21.37  0.28  1.29%

Sr. VP of Global Operations
Dr. Frank Scholz is Executive Vice President and Chief Operations and Digital Innovation Officer of the Company. He joined Mallinckrodt in March 2014 as Senior Vice President of Global Operations and assumed the position of Executive Vice President of Global Operations and President, Specialty Generics in September 2016. Prior to joining Mallinckrodt, Dr. Scholz was a partner with McKinsey Co, a global management consulting firm first in its Hamburg, Germany office and then in its Chicago, Illinois office
Age: 48  SVP Since 2018      
44 17 8463 6700  http://www.mallinckrodt.com
Scholz was a leader in McKinsey?s global pharmaceutical and operations practices. He joined McKinsey in 1997.

Frank Scholz Latest Insider Activity

Management Efficiency

The company has Return on Asset of 2.18 % which means that on every $100 spent on asset it made $2.18 of profit. This is way below average. In the same way, it shows return on shareholders equity (ROE) of 30.63 % implying that it generated $30.63 on every 100 dollars invested.
The company has 6.81 B in debt with debt to equity (D/E) ratio of 105.4 . This implies that the company may be unable to create cash to meet all of its financial commitments. Mallinckrodt Public Limited Company has Current Ratio of 2.06 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.

Similar Executives

Found 3 records

SVP Since

Sherry KorczynskiEagle Pharmaceuticals
N/A
Judy JoiceDURECT Corporation
2014
John MaslowskiFibrocell Science
2017

Entity Summary

Mallinckrodt public limited company develops, manufactures, markets, and distributes branded pharmaceutical products in Canada and the European Union, as well as in Latin American, the Middle Eastern, African, and the Asia-Pacific regions. The company is based in Staines-Upon-Thames, the United Kingdom. Mallinckrodt Public operates under Drug Manufacturers - Specialty Generic classification in USA and traded on New York Stock Exchange. It employs 00 people.Mallinckrodt Public Limited Company (MNK) is traded on BATS Exchange in USA. It is located in IRELAND and employs 3,900 people. Mallinckrodt Public is listed under Pharmaceutical Products category by Fama And French industry classification.

Mallinckrodt Public Leadership Team

Gary Phillips, President
Steven Romano, President, Ph.D
Mark Casey, Executive
JoAnn Reed, Director
Virgil Thompson, Director
Diane Gulyas, Director
Joseph Zaccagnino, Director
Paul Carter, Director
David Carlucci, Director
Frank Scholz, SVP
David Norton, Director
Hugh ONeill, President
Martin Carroll, Director, MBA
Steve Romano, President, Ph.D
Mark Trudeau, CEO
Kneeland Youngblood, Director, Ph.D
Meredith Fischer, President
Terrance Carlson, President
Ian Watkins, SVP
Melvin Booth, Chairman, Ph.D
Raymond Furey, President
Angus Russell, Director, Ph.D
Ronald Lloyd, President
Karen Sheehy, Executive
Matthew Harbaugh, CFO
MichaelBryant Hicks, Executive
Anne Whitaker, Director

Stock Performance Indicators

Did you try this?

Run Money Managers Now
   

Money Managers

Screen money managers from public funds and ETFs managed around the world
All  Next Launch Money Managers

Build Optimal Portfolios

Align your risk with return expectations
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see also Stocks Correlation. Please also try Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.